Leading the way to safer medication
 Crosscheck  Recommender


Therapeutic Indications

Caffeine is indicated for:

Primary apnoea of premature newborns

Irrespective of gender only Newborns (0 - 40 days old)

Cafferine is indicated for the treatment of primary apnoea of premature newborns.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 5-20 mg/kg body weight


Active ingredient Caffeine is contraindicated in the following cases: